(Photo by Photofusion/Universal Images Group via Getty Images)
The evidence supporting the use of psychedelic drugs to treat treatment-resistant depression continues to build. In the latest volley, a study finds that psilocybin, the psychoactive ingredient in magic mushrooms, may open an entirely new door to treating depression – by allowing deeply entrenched beliefs to become changeable.
Read more at Forbes – Original article by David DiSalvo.